POS-719 Outcomes of borderline T-cell rejection among kidney transplant patients at National Kidney & Transplant Institute
M.A. GARIBAY, A.R. Villanueva T, I.D.A. How-Tan L
Kidney International Reports · 2021
doi:10.1016/j.ekir.2021.03.751 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
In the 2005 Banff update, the classification has controversially expanded the borderline T-cell rejection (BL-R) category to include: “foci of tubulitis with minor/absent interstitial infiltration; or interstitial infiltration with mild tubulitis”; while excluding samples with any intimal arteritis. Currently, the management of BL-R is still under debate with no final guideline to manage this category. This study will review the clinical course of patients whose renal allograft biopsies showed
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.